Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: a multicentre retrospective cohort study

• Brian D. Rankin,
• Jorge-Ryan Georgakopoulos,
• Muskaan Sachdeva,
• Asfandyar Mufti,
• Alim R. Devani,
• Melinda J. Gooderham,
• Chih-Ho Hong,
• Vipul Jain,
• Perla Lansang,
• Ronald Vender,
• Jensen Yeung,
• Vimal H. Prajapati

Affiliations

Brian D. Rankin

Cumming School of Medicine, University of Calgary

Jorge-Ryan Georgakopoulos

Division of Dermatology, Department of Medicine, University of Toronto

Muskaan Sachdeva

Faculty of Medicine, University of Toronto

Asfandyar Mufti

Division of Dermatology, Department of Medicine, University of Toronto

Alim R. Devani

Dermatology Research Institute

Melinda J. Gooderham

Queen's University

Chih-Ho Hong

Department of Dermatology and Skin Science, University of British Columbia

Vipul Jain

Division of Clinical Immunology and Allergy, McMaster University

Perla Lansang

Division of Dermatology, Department of Medicine, University of Toronto

Ronald Vender

Department of Dermatology, McMaster University

Jensen Yeung

Division of Dermatology, Department of Medicine, University of Toronto

Vimal H. Prajapati

Dermatology Research Institute